Drug Shortage Report for APO-PREGABALIN

Last updated on 2017-05-10 History
Report ID 450
Drug Identification Number 02394243
Brand name APO-PREGABALIN
Common or Proper name PREGABALIN
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) PREGABALIN
Strength(s) 50MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 100 BTL & 500 BTL
ATC code N03AX
ATC description ANTIEPILEPTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-02-14
Estimated end date 2017-06-09
Actual end date 2017-05-08
Shortage status Resolved
Updated date 2017-05-10
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2017-03-11 English Compare
v2 2017-03-11 French Compare
v3 2017-05-10 English Compare
v4 2017-05-10 French Compare

Showing 1 to 4 of 4